Capsule
PRADAXA CAP 110MG
Summary
PRADAXA CAP 110MG — Capsule containing dabigatran etexilate (as mesilate). Hong Kong Registration No. HK-57315. Certificate Holder: BOEHRINGER INGELHEIM (HK) LTD. Date of Registration: 30 Dec, 2008.
Product NamePRADAXA CAP 110MG
Registration No.HK-57315
Certificate HolderBOEHRINGER INGELHEIM (HK) LTD
Holder AddressSUITES 1504-9 GREAT EAGLE CENTRE, 23 HARBOUR RD, WAN CHAI, HONG KONG
Ingredientsdabigatran etexilate (as mesilate)
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration30 Dec, 2008
ATC codesB01AE07
ATC Classification
ATC level 1
B Blood and Blood Forming Organs
All ATC groupsB01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。